BioSpace News Archive

XENEX, a world leader in UV technology-based infection reduction strategies and solutions, chose AT&T* to connect their LightStrike™ Germ-Zapping Robots™ which use intense pulsed

HeroX, the leading crowdsourcing platform that solves global problems, today announced the launch of a resource hub to pool all COVID-related challenges, from an array of crowdsourcing platforms, into one accessible place.

The fastest recipe for worldwide access to a coronavirus vaccine may be to build upon on an existing vaccine with an already established manufacturing and supply chain.

A $500,000 donation will support a variety of efforts, including the development and dissemination of research, education and scientific recommendations to doctors and health care providers during this emergency [07-April-2020] RIDGEFIELD, Conn. , April 7, 2020 /PRNewswire/ -- As part of Boehringer Ingelheim’s commitment to fighting the COVID-19 pandemic and long-stan

nScrypt’s research arm, Sciperio, is collaborating with the Uniformed Services University of the Health Sciences’ 4D Bio3 program, The Geneva Foundation, Safi Biosolutions, Advanced Bioprocess Services, and Massachusetts General Hospital to create solutions for future blood supply by making on demand human blood.

Sharp Fluidics®, LLC, a private medical device company whose innovative Operative Armour® System leads the way in open surgery closure efficiency and safety, announced the acquisition of neoClose®, a laparoscopic and robotic port site closure technology from neoSurgical, LTD.

Immunologix Laboratories announces the appointment of Lauren Stevenson , Ph.D . as Chief Scientific Officer and further expands the Translational Sciences team, as Christopher Stebbins , Ph.D. joins the drug development experts as Scientific Director. Ensuring strong leadership and continuous scientific growth is a key objective fo

Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announces that its independently developed Detection Kit for Novel Coronavirus (SARS-CoV-2) RNA (PCR-Fluorescence Probing) has been issued CE marking and had its application accepted by FDA-EUA

Moderna, Inc. announced that it will host its virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Tuesday, April 14.

Elanco Animal Health Incorporated will announce its first quarter 2020 financial results on Thursday, May 7, 2020.